Mostrar el registro sencillo del ítem

dc.contributor.authorVázquez Alberdi, Lucia
dc.contributor.authorMartínez-Busi, Marcela
dc.contributor.authorArrarte, Eloisa
dc.contributor.authorEcheverry, Carolina
dc.contributor.authorCalero, Miguel 
dc.contributor.authorKun, Alejandra
dc.date.accessioned2024-07-12T07:30:49Z
dc.date.available2024-07-12T07:30:49Z
dc.date.issued2024-05-07
dc.identifier.citationDiscov Nano. 2024 May 7;19(1):81.es_ES
dc.identifier.urihttp://hdl.handle.net/20.500.12105/20522
dc.description.abstractCurcumin is a polyphenol extracted from Curcuma longa's roots. Low doses of curcumin are related to anti-inflammatory, antioxidant, and neuroprotective effects, while high doses are used for their lethality. This diversity of behaviors allows us to understand curcumin as a compound with hormetic action. Due to its strongly hydrophobic character, curcumin is often solubilized in organic compounds. In this way, we have recently reported the undesirable and occasionally irreversible effects of alcohol and DMSO on the viability of primary Schwann cell cultures. In this scenario, the use of nanoparticles as delivery systems has become a successful alternative strategy for these compounds. In the present work, we describe the structure of Polydopamine (PDA) nanoparticles, loaded with a low dose of curcumin (Curc-PDA) without the use of additional organic solvents. We analyzed the curcumin released, and we found two different forms of curcumin. Small increased cell viability and proliferation were observed in endoneurial fibroblast and Schwann cell primary cultures when Curc-PDA was steadily supplied for 5 days. The increased bioavailability of this natural compound and the impact on cells in culture not only confirm the properties of curcumin at very low doses but also provide a glimpse of a possible therapeutic alternative for PNS conditions in which SCs are involved.es_ES
dc.description.sponsorshipThis work was supported by Agencia Nacional de Investigación e Innovación (ANII), Uruguay [grant numbers: FCE_1_2019_1_155539; POS_NAC_2022_1_173578], the PEDECIBA, CSIC-UdelaR and SNI-ANII. From the Spanish, Ministry of Science and Innovation and the Spanish CIBERNED network [grant PID2019-110401RB-100]es_ES
dc.language.isoenges_ES
dc.publisherSpringer es_ES
dc.type.hasVersionVoRes_ES
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subjectCurcumines_ES
dc.subjectPolydopamine-nanoparticleses_ES
dc.subjectHormesises_ES
dc.subjectViabilityes_ES
dc.subjectProliferationes_ES
dc.titleA low dose of curcumin-PDA nanoparticles improves viability and proliferation in endoneurial fibroblasts and Schwann cell cultureses_ES
dc.typeresearch articlees_ES
dc.rights.licenseAtribución 4.0 Internacional*
dc.identifier.pubmedID38714630es_ES
dc.format.volume19es_ES
dc.format.number1es_ES
dc.format.page81es_ES
dc.identifier.doi10.1186/s11671-024-04023-7es_ES
dc.contributor.funderAgencia Nacional de Investigación e Innovación (Uruguay) es_ES
dc.contributor.funderConsejo Superior de Investigaciones Científicas (España) es_ES
dc.contributor.funderMinisterio de Ciencia e Innovación (España) es_ES
dc.contributor.funderCentro de Investigación Biomédica en Red - CIBERNED (Enfermedades Neurodegenerativas) es_ES
dc.description.peerreviewedes_ES
dc.identifier.e-issn2731-9229es_ES
dc.relation.publisherversionhttps://doi.org/10.1186/s11671-024-04023-7es_ES
dc.identifier.journalDiscover nanoes_ES
dc.repisalud.centroISCIII::Unidad Funcional de Investigación de Enfermedades Crónicas (UFIEC)es_ES
dc.repisalud.institucionISCIIIes_ES
dc.rights.accessRightsopen accesses_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/PID2019-110401RB-100es_ES


Ficheros en el ítem

Acceso Abierto
Thumbnail
Acceso Abierto
Thumbnail

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Atribución 4.0 Internacional
Este Item está sujeto a una licencia Creative Commons: Atribución 4.0 Internacional